Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nanjing
Clinical trial register · China

Clinical Trials in Nanjing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University203 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School87 Nanjing First Hospital, Nanjing Medical University72 Nanjing Medical University30 The Second Hospital of Nanjing Medical University30
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Nanjing

1211 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
100
Nanjing
2025-07-24
Recruiting
Celcuity Inc
Phase 3
1,180
Beijing, Quanzhou, Luoyang, Xinxiang, Zhengzhou, Changsha, Shaoyang, Nanjing
2025-07-24
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2025-07-20
Not yet open
Nanjing First Hospital, Nanjing Medical University
Phase 4
40
Nanjing
2025-07-20
Active, closed
Nanjing Bioheng Biotech Co., Ltd.
Early Phase 1
3
Nanjing
2025-07-20
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
20
Nanjing
2025-07-20
Recruiting
Bristol-Myers Squibb
Phase 3
450
Beijing, Guangzhou, Baoding, Changsha, Nanjing, Xi'an, Chengdu, Tianjin
2025-07-18
Active, closed
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033Primary Myelofibrosis, Myeloproliferative Neoplasm
DrugBesremi
PharmaEssentia
Phase 3
160
Beijing, Chongqing, Guangdong, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing
2025-07-18
Recruiting
Daiichi Sankyo
Phase 2
130
Beijing, Changchun, Guangzhou, Hangzhou, Nanchang, Nanjing, Nanning, Qingdao
2025-07-18
Not yet open
Southeast University, China
Observational
5,775
Nanjing
2025-07-18
Recruiting
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
594
Beijing, Shenzhen, Nanjing, Hangzhou
2025-07-16
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
15
Nanjing
2025-07-15
Active, closed
Aligos Therapeutics
Phase 2
200
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Shanghai
2025-07-15
Recruiting
Zhongda Hospital
Not applicable
76
Nanjing
2025-07-15
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
68
Nanjing
2025-07-12
Recruiting
Bristol-Myers Squibb
Phase 3
426
Beijing, Haidian District, Chongqing, Guangzhou, Shenzhen, Changsha, Nanjing, Shanghai
2025-07-10
Recruiting
MITRIS China Post Market Clinical Follow-up (PMCF) Study
NCT07059793Mitral Valve Replacement
Edwards Lifesciences
Observational
250
Beijing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Nanjing, Xi'an, Jinan
2025-07-08
Active, closed
Sanofi
Phase 2
105
Huizhou, Guangzhou, Nanjing, Suzhou, Wuxi, Shanghai, Hangzhou, Ningbo
2025-07-07
Recruiting
Smith & Nephew, Inc.
Not applicable
105
Guangzhou, Zhengzhou, Nanjing, Changchun, Hangzhou
2025-07-02
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Beijing, Xuzhou, Changchun, Chengdu, Chongqing, Guangzhou, Hefei, Nanjing
2025-07-02
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
142
Nanjing
2025-07-01
Recruiting
Lanyue Zhu
Observational
1,000
Nanjing
2025-07-01
Recruiting
Novartis Pharmaceuticals
Phase 3
940
Fuzhou, Guangzhou, Wuhan, Nanjing, Shenyang, Chengdu, Hangzhou, Beijing
2025-07-01
Recruiting
Lanyue Zhu
Observational
10,000
Nanjing
2025-07-01
By invitation
Nanjing Medical University
Observational
438
Nanjing
2025-07-01
Not yet open
Precision OSA Therapy Based on Phenotypes and Endotypes
NCT06825923Obstructive Sleep Apnea
Nanjing Medical University
Observational
200
Nanjing
2025-07-01
Active, closed
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1
50
Nanjing
2025-07-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 4
464
Nanjing
2025-07
Active, closed
Takeda
Phase 3
13
Changping, Dongcheng, Nanjing, Siming
2025-06-26
Active, closed
HELP Therapeutics Co., Ltd.
Phase 1
9
Nanjing
2025-06-20
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 3
198
Nanjing
2025-06-20
Recruiting
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Phase 1
36
Nanjing, Beijing, Shanghai
2025-06-18
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
98
Nanjing
2025-06-17
Not yet open
Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer
NCT06848439Mouth Neoplasms, Neoadjuvant Therapy, Immunotherapy, Molecular Targeted Therapy
Jiangsu Cancer Institute & Hospital
Phase 2
26
Nanjing
2025-06-15
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
NCT06933472Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease), Dialysis
Alebund Pharmaceuticals
Phase 3
264
Beijing, Xiamen, Zhengzhou, Wuhan, Changsha, Nanjing, Nantong, Wuxi
2025-06-13
Recruiting
The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM
NCT07050381Arteriovenous Malformation of Central Nervous System, Aneurysm, Ruptured, Aneurysmatic Subarachnoid Haemorrhage, Aneurysm Cerebral
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2025-06-13
Recruiting
Celgene
Phase 2
120
Hefei, Beijing, Wuhan, Nanjing, Shanghai Shi, Hangzhou
2025-06-09
Recruiting
Jianfeng Xie
Observational
1,846
Nanjing
2025-06-08
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
1,450
Nanjing, Shanghai
2025-06-03
Recruiting
Minhu Chen
Observational
234
Guangzhou, Nanjing, Huangpu, Hangzhou
2025-06-03
Active, closed
The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome.
NCT07071597Nephrotic Syndrome, Adolescent, Biopsy
Nanjing Children's Hospital
Observational
400
Nanjing
2025-06-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
500
Nanjing
2025-06-01
Recruiting
Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy
NCT07141225Renal and Urinary Disorders, Renal Cancer, Renal Particial
Shao Pengfei
Not applicable
190
Nanjing
2025-06-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
120
Nanjing
2025-06-01
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
80
Nanjing
2025-06-01
Not yet open
Zhongda Hospital
Not applicable
208
Nanjing
2025-06
Not yet open
PFA-based Bi-atrial Maze-like Catheter Ablation for PeAF
NCT06952023Atrial Fibrillation, Persistent Atrial Fibrillation
The First Affiliated Hospital of Dalian Medical University
Not applicable
390
Nanjing, Dalian, Ningbo
2025-06
Not yet open
Nanjing First Hospital, Nanjing Medical University
Observational
839
Nanjing
2025-06
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
3,000
Xinyang, Nanjing
2025-05-30
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
Beijing, Chongqing, Fuzhou, Nanning, Zhengzhou, Nanjing, Shanghai
2025-05-28
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Nanjing, Nanchang, Xi'an, Heze, Jinan
2025-05-26
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
168
Nanjing
2025-05-25
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 1
30
Hefei, Beijing, Shijiazhuang, Zhengzhou, Wuhan, Nanjing
2025-05-23
Recruiting
Nanjing Tianyinshan Hospital
Not applicable
270
Nanjing
2025-05-22
Active, closed
AstraZeneca
Phase 2
16
Jinan, Nanjing, Shanghai
2025-05-20
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
24
Nanjing
2025-05-20
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
Pfizer
Phase 2
252
Beijing, Guangzhou, Baotou, Hohhot, Najing, Nanjing, Xuzhou, Nanchang
2025-05-20
Recruiting
Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ
NCT06985602Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2
30
Nanjing
2025-05-16
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
364
Nanjing
2025-05-14
Recruiting
Chongqing Precision Biotech Co., Ltd
Phase 1
60
Nanjing
2025-05-08
Active, closed
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
6
Nanjing
2025-05-08
By invitation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
29
Nanjing
2025-05-04
Recruiting
Acupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy
NCT07907536Diabetic Cardiovascular Autonomic Neuropathy, Type 2 Diabetes Mellitus, Diabetic Neuropathies
DrugMecobalamin
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
60
Nanjing
2025-05-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
28
Nanjing
2025-05-01
Recruiting
Shao Pengfei
Not applicable
232
Nanjing
2025-05-01
Not yet open
Mindfulness-Enhanced Dual-Task Training in PD-MCI
NCT06930742Mild Cognitive Impairment (MCI), Parkinson's Disease (PD)
Nanjing Mingzhou Rehabilitation Hospital
Not applicable
90
Nanjing
2025-05-01
Active, closed
Nanjing First Hospital, Nanjing Medical University
Not applicable
152
Nanjing
2025-05-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
50
Nanjing
2025-05-01
Recruiting
Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury
NCT06819462Ventilator-Associated Pneumonia (VAP), Inha'le'd
DrugColistin
Southeast University, China
Not applicable
444
Nanjing
2025-04-27
Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1/2
146
Beijing, Guangzhou, Nanjing, Shanghai
2025-04-25
Recruiting
VA Dual Sequential Therapy
NCT06929962Helicobacter Pylori Infection
The First Affiliated Hospital with Nanjing Medical University
Phase 4
600
Nanjing
2025-04-24
Recruiting
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery
NCT07062952Kidney Tumors, CKD, Salt Substitute, Nephrectomy
Jinling Hospital, China
Not applicable
200
Nanjing
2025-04-24
Active, closed
Zhejiang Doer Biologics Co., Ltd.
Phase 2
110
Hangzhou, Changchun, Nanjing
2025-04-22
Recruiting
Geriatric Hospital of Nanjing Medical University
Phase 1/2
55
Nanjing
2025-04-21
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
74
Nanjing
2025-04-21
Recruiting
baotai Liang
Phase 2
93
Nanjing
2025-04-20
Recruiting
Sun Jing
Phase 2
30
Nanjing
2025-04-20
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
120
Nanjing
2025-04-17
Active, closed
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
NCT06900543Unresectable Hepatocellular Carcinoma
DrugSIRT
Chengdu New Radiomedicine Technology Co. LTD.
Phase 3
108
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Shenyang, Xi’an, Chengdu
2025-04-15
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
72
Beijing, Chongqing, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Shenyang
2025-04-11
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
245
Guiyang, Nanjing, Shanghai
2025-04-11
Recruiting
Nanjing IASO Biotechnology Co., Ltd.
Phase 1
70
Nanjing, Tianjin
2025-04-11
Recruiting
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer
Nanjing First Hospital, Nanjing Medical University
Observational
20
Nanjing
2025-04-10
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
DrugsRibociclib·Fulvestrant
Novartis Pharmaceuticals
Phase 1/2
280
Nanjing, Xian
2025-04-03
Recruiting
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
NCT06909708Unresectable Hepatocellular Carcinoma
Zhongda Hospital
Not applicable
108
Nanjing
2025-04-03
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Early Phase 1
15
Nanjing
2025-04-02
Recruiting
Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU
NCT07596589Remimazolam Besylate, Mechanically Ventilated ICU Patients, Sedation
DrugsRemimazolam·Propofol
Southeast University, China
Phase 3
80
Nanjing
2025-04-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2025-04-01
Not yet open
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer
NCT06838520Prostate Cancer (Adenocarcinoma)
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Changzhou, Nanjing, Suzhou, Yangzhou
2025-04-01
Not yet open
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
240
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Not yet open
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3
110
Beijing, Cangzhou, Wuhan, Yichang, Changsha, Nanjing, Suzhou, Taizhou
2025-04
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
20
Nanjing
2025-03-31
Not yet open
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-03-31
Active, closed
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 4
36
Nanjing
2025-03-29
Recruiting
Zhejiang Raygene Pharmaceuticals Co., Ltd
Phase 2/3
300
Nanjing, Lishui
2025-03-27
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2025-03-24
Recruiting
Bayer
Phase 1/2
450
Beijing, Wuhan, Nanjing, Hangzhou
2025-03-21
Recruiting
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Phase 3
228
Nanjing
2025-03-20
Recruiting
Real-World Study of PADN for the Treatment of PAH
NCT07039604Pulmonary Hypertension, Hypertension, Pulmonary Arterial
Pulnovo Medical (Wuxi) Co., Ltd.
Observational
200
Nanjing
2025-03-19
Recruiting
baotai Liang
Phase 2
96
Nanjing, Nantong
2025-03-19
Recruiting
Sun Jing
Phase 2
22
Nanjing
2025-03-15
Recruiting
Bristol-Myers Squibb
Phase 3
60
Beijing, Chongqing, Guangzhou, Nanjing, Changchun, Hangzhou, Shanghai
2025-03-13
Active, closed
Celgene
Phase 3
960
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Huizhou, Changzhou, Nanjing
2025-03-13
Recruiting
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
200
Nanjing
2025-03-10
Not yet open
Peking University
Phase 1
48
Beijing, Nanjing
2025-03-10
By invitation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
186
Nanjing
2025-03-09
Recruiting
AbbVie
Phase 1/2
252
Beijing, Fuzhou, Liuzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nanchang
2025-03-06
Recruiting
The Second Hospital of Nanjing Medical University
Phase 1/2
20
Nanjing
2025-03-06
Recruiting
BeOne Medicines
Phase 3
300
Beijing, Chongqing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Xuzhou
2025-03-05
Not yet open
Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999Atrial Fibrillation, Atrial Fibrillation, Paroxysmal or Persistent, Deep Sedations, Conscious Sedation
The First Affiliated Hospital of Dalian Medical University
Not applicable
1,334
Hefei, Guangzhou, Nanjing, Suzhou, Nanchang, Dalian, Qingdao, Shanghai
2025-03-03
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Observational
655
Nanjing
2025-03-01
Not yet open
Ying Gao
Observational
4,460
Lanzhou, Harbin, Zhengzhou, Nanjing, Xuzhou, Changchun, Jining, Xian
2025-03-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
980
Zhengzhou, Changzhou, Nanjing, Suzhou, Xi’an
2025-03-01
Not yet open
Guangzhou Jiayin Biotech Ltd
Phase 1/2
16
Nanjing, Hangzhou
2025-03-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Not applicable
160
Nanjing
2025-03-01
Recruiting
Multimodal Phenotyping in Adolescent Inpatient Depression: An Observational Study
NCT07247344Adolescent, Major Depressive Disorder (MDD, Bipolar Disorder (BD)
Jiangsu Province Nanjing Brain Hospital
Observational
1,000
Nanjing
2025-03-01
Not yet open
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
NCT06866600Heart Failure, Heart Failure At NYHA Stage III or IV
HELP Therapeutics Co., Ltd.
Phase 1/2
40
Nanjing
2025-03
Recruiting
Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease
NCT06843005Major Adverse Cardiovascular Events (MACE), Prevention, Coronary Artery Disease(CAD), CT Angiography
Zhang longjiang,MD
Not applicable
3,100
Nanjing
2025-02-28
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
327
Beijing, Fuzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2025-02-27
Recruiting
Novartis Pharmaceuticals
Phase 2/3
443
Fuzhou, Wuhan, Nanjing, Shenyang, Xian, Chengdu, Beijing, Guangzhou
2025-02-27
Recruiting
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
1,000
Nanjing
2025-02-25
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 3
88
Nanjing
2025-02-24
Active, closed
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
33
Bengbu, Jiangmen, Xingtai, Harbin, Luohe, Changsha, Nanjing, Nantong
2025-02-20
Active, closed
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Not yet open
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Not yet open
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Not yet open
CMTS0929 for Clostridioides Difficile Infection
NCT06836427Clostridioides Difficile Infection
DrugCMTS0929
The Second Hospital of Nanjing Medical University
Early Phase 1
12
Nanjing
2025-02-20
Not yet open
CMTS0929 for Inflammatory Bowel Disease
NCT06844708Inflammatory Bowel Disease (IBD)
DrugCMTS0929
The Second Hospital of Nanjing Medical University
Early Phase 1
12
Nanjing
2025-02-20
Recruiting
baotai Liang
Phase 2/3
83
Nanjing
2025-02-16
Recruiting
Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
NCT06821685Abortion, Habitual, Infertility Unexplained, Embryo Implantation, Pre-Eclampsia
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1
14
Nanjing
2025-02-13
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 2
240
Nanjing
2025-02-07
Recruiting
Shanghai Yizhong Pharmaceutical Co., Ltd.
Phase 3
416
Nanjing, Shanghai
2025-02-05
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
428
Nanjing
2025-02-01
Recruiting
The Second Hospital of Nanjing Medical University
Observational
24
Nanjing
2025-02-01
Recruiting
Nanjing Medical University
Not applicable
100
Nanjing
2025-02-01
Recruiting
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
NCT06762782Hepatocellular Carcinoma (HCC), Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University
Phase 2
276
Nanjing
2025-02
Not yet open
Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures
NCT06762704The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,408
Hefei, Nanjing, Nanchang, Xi'an, Shanghai
2025-02
Recruiting
Zhongda Hospital
Observational
332
Nanjing
2025-01-31
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
840
Nanjing
2025-01-30
Recruiting
Phase III Trial of VDJ001 In Patients With Idiopathic Multicentric Castleman Disease
NCT07872423Anti IL-6R, Castleman's Disease, Multicentric
Beijing VDJBio Co., LTD.
Phase 3
45
Beijing, Xiamen, Wuhan, Nanjing, Nanchang, Taiyuan, Chengdu, Hangzhou
2025-01-27
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
236
Nanjing
2025-01-25
Recruiting
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
NCT07175480Renal Cell Carcinoma (RCC), Metastatic Renal Cell Carcinoma (mRCC)
DrugVegfr-Tki
Jinling Hospital, China
Phase 2
30
Nanjing
2025-01-24
Recruiting
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2
84
Beijing, Fuzhou, Foshan, Zhengzhou, Changsha, Nanjing, Nanchang, Shenyang
2025-01-23
Recruiting
Effects of Face Mask Continuous Positive Airway Pressure Vs. Noninvasive Ventilation Vs. High-flow Nasal Oxygen on Intubation-free Survival in Acute Hypoxemic Respiratory Failure: the TRIPOD Randomized Clinical Trial
NCT06795971Acute Hypoxemic Respiratory Failure, High-Flow Nasal Oxygen Therapy, Noninvasive Ventilation, Continuous Positive Airway Pressure (CPAP)
Southeast University, China
Not applicable
1,300
Nanjing
2025-01-23
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
NCT06823427Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent, Urothelial Carcinoma of the Renal Pelvis and Ureter
Drugs9MW2821·JS001·Toripalimab
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2
60
Changsha, Nanjing
2025-01-17
Recruiting
Shanghai Auzone Biological Technology Co., Ltd.
Phase 2
150
Beijing, Changsha, Chengdu, Nanjing, Tianjin
2025-01-13
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Active, closed
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
3,000
Nanjing
2025-01-08
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2025-01-08
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
47
Nanjing
2025-01-03
Recruiting
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
NCT06764238Acute Lymphoblastic Leukemia ALL, Childhood Leukemia, Acute Lymphoblastic, B Cell Acute Lymphoblastic Leukemia (B-ALL)
DrugsBlinatumomab·Methotrexate·Vincristine·Venetoclax
Institute of Hematology & Blood Diseases Hospital, China
Phase 2/3
1,800
Hefei, Fuzhou, Guangzhou, Nanning, Guiyang, Wuhan, Changsha, Nanjing
2025-01-03
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
58
Nanjing
2025-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
800
Nanjing
2025-01-01
By invitation
Band Versus Ring for Tricuspid Regurgitation
NCT04093297Tricuspid Regurgitation
Nanjing Medical University
Not applicable
300
Nanjing
2025-01-01
By invitation
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
Recruiting
Optimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916Renal Neoplasms, Pathology, Renal Cell Cancer
Shao Pengfei
Observational
2,100
Nanjing
2025-01-01
Not yet open
Nanjing Medical University
Not applicable
120
Beijing, Nanjing
2025-01-01
Recruiting
Optic Nerve Injury in Obstructive Sleep Apnea Patients
NCT06748703Obstructive Sleep Apnea (OSA), Ischemic Optic Neuropathy/Optic Nerve Stroke
Nanjing Medical University
Not applicable
80
Nanjing
2025-01-01
Recruiting
The Second Hospital of Nanjing Medical University
Observational
100
Nanjing
2025-01-01
Recruiting
Shao Pengfei
Observational
300
Nanjing
2025-01-01
Recruiting
Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy
NCT07586787Proliferative Diabetic Retinopathy (PDR)
Xiamen Ophthalmology Center Affiliated to Xiamen University
Not applicable
100
Beijing, Xiamen, Zhengzhou, Nanjing, Dalian
2025-01-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
30
Nanjing
2025-01-01
Recruiting
Second Xiangya Hospital of Central South University
Not applicable
3,000
Beijing, Guangzhou, Shenzhen, Luoyang, Changsha, Nanjing, Shenyang, Chengdu
2025-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
150
Nanjing
2025-01-01
Recruiting
Nanjing Medical University
Observational
80
Nanjing
2025-01-01
Not yet open
Nanjing Medical University
Not applicable
400
Beijing, Nanjing
2025-01-01
Not yet open
InnoBM Pharmaceuticals Co., Ltd.
Phase 3
228
Bengbu, Anyang, Zhengzhou, Nanjing, Lishui, Guangzhou, Lanzhou, Luoyang
2025-01
Not yet open
Chinese Medical Association
Observational
600
Nanjing
2025-01
By invitation
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
60
Nanjing
2024-12-31
By invitation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
128
Nanjing
2024-12-31
Recruiting
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
NCT06849180Combined Hepatocellular-cholangiocarcinoma, Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma
Zhongda Hospital
Observational
198
Nanjing
2024-12-31
By invitation
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
300
Nanjing
2024-12-31
Recruiting
Zhejiang Wenda Pharma Technology LTD.
Phase 2
140
Nanjing
2024-12-31
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
180
Nanjing
2024-12-31
Not yet open
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
NCT06762223Metabolic Dysfunction-associated Steatotic Liver Disease, Type 2 Diabetes Mellitus
DrugsHenagliflozin·Metformin
Xiqiao Zhou
Phase 4
190
Nanjing
2024-12-31
Recruiting
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
480
Nanjing
2024-12-30
Recruiting
Effect of Subanesthetic Dose of Esketamine on Sleep Quality
NCT06773143Insomnia, Breast Cancer Surgery, Esketamine
DrugEsketamine
Nanjing First Hospital, Nanjing Medical University
Not applicable
184
Nanjing
2024-12-30
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
92
Nanjing
2024-12-28
Recruiting
Nanjing Children's Hospital
Phase 1
12
Nanjing
2024-12-28
Recruiting
Nanjing First Hospital, Nanjing Medical University
Observational
30
Nanjing
2024-12-25
Recruiting
Ruijin Hospital
Early Phase 1
66
Wuhan, Nanjing, Shanghai
2024-12-23
Recruiting
Kezhong Zhang
Not applicable
12
Nanjing
2024-12-23
Recruiting
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
NCT06715007Stroke, Ischemic, Small Vessel Cerebrovascular Disease, White Matter Hyperintensity
DrugsCilostazol·Clopidogrel·Aspirin
The First Affiliated Hospital with Nanjing Medical University
Observational
300
Nanjing
2024-12-20
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-12-20
Recruiting
Shupei Li
Not applicable
10
Nanjing
2024-12-20
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
138
Guangzhou, Nanning, Wuhan, Changsha, Nanjing, Jinan, Linyi, Chengdu
2024-12-17
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
206
Nanjing, Chengdu
2024-12-17
Recruiting
GlaxoSmithKline
Phase 3
520
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai
2024-12-16
Recruiting
Shupei Li
Not applicable
5
Nanjing
2024-12-15
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
150
Guangzhou, Shenzhen, Zhengzhou, Nanjing, Nanchang, Shanghai, Xi’an, Chengdu
2024-12-09
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 2
45
Nanjing
2024-12-03
Active, closed
Sintilimab in Combination with Chemotherapy ± Local Treatment for Om-G/GEJ
NCT06739161Gastroesophageal Junction Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2
120
Nanjing
2024-12-02
Active, closed
The First Affiliated Hospital with Nanjing Medical University
Phase 3
416
Nanjing
2024-12-01
By invitation
Correlation Analysis of Xpert Carba-R Detection of Non-colonized CRE in BALF and Rectal Swabs From Patients With LRTI
NCT06636890Carbapenem-Resistant Enterobacteriaceae, Lower Respiratory Tract Infections
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2024-12-01
Not yet open
Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer
NCT06662708Prostate Cancer, Prostate Intraductal Carcinoma, Prostate Cancer Aggressiveness, Prostate Cancer Stage
Shao Pengfei
Not applicable
200
Nanjing
2024-12-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
60
Nanjing
2024-12-01
Not yet open
Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)
NCT06707350Cardiopulmonary Bypass, Cardiovascular Diseases, Inflammatory Response During Cardiac Surgery
Nanjing Medical University
Not applicable
500
Nanjing
2024-12-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
234
Nanjing
2024-12-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
60
Nanjing
2024-12-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-12
Not yet open
Cheng Lei
Not applicable
60
Nanjing
2024-12
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 2
70
Nanjing
2024-11-30
Active, closed
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
94
Nanjing
2024-11-28
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Chengdu, Guangzhou, Nanchang, Nanjing, Nantong, Shandong, Shanghai, Tianjin
2024-11-27
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
30
Nanjing
2024-11-25
Not yet open
Washed Microbiota Transplantation in Solid Organ Transplantation
NCT06708676Solid Organ Transplant Complications
The Second Hospital of Nanjing Medical University
Not applicable
50
Nanjing
2024-11-20
Active, closed
Daiichi Sankyo
Phase 3
700
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Jinan, Nanchang, Nanjing
2024-11-19
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
260
Nanjing
2024-11-19
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
70
Nanjing
2024-11-15
Active, closed
BeOne Medicines
Phase 2
94
Fuzhou, Zhengzhou, Changzhou, Nanjing, Shanghai, Hangzhou
2024-11-14
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-11-14
Active, closed
Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.
NCT07212426PNH - Paroxysmal Nocturnal Hemoglobinuria
DrugLP-005
Longbio Pharma
Phase 2
30
Nanjing
2024-11-14
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-11-14
By invitation
Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis
NCT06976099Acute Pancreatitis (AP), Hypertriglyceridemia Acute Pancreatitis
Peking Union Medical College Hospital
Observational
1,000
Beijing, Guangzhou, Zunyi, Harbin, Changsha, Nanjing, Yangzhou, Dalian
2024-11-13
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 3
1,000
Nanjing
2024-11-07
Recruiting
Affiliated Hospital of Nantong University
Phase 2
30
Nanjing
2024-11-04
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
70
Nanjing
2024-11-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 1
200
Nanjing
2024-11-01
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
100
Nanjing
2024-11-01
Recruiting
Peking University People's Hospital
Observational
50
Beijing, Harbin, Nanjing, Shenyang, Xi'an
2024-10-26
Recruiting
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
NCT06456528Cancer Treatment-Induced Thrombocytopenia
Qilu Pharmaceutical Co., Ltd.
Phase 2/3
235
Harbin, Nanjing
2024-10-22
By invitation
Clinical Classification and Imaging Markers in Patients of Obesity
NCT06649071Obesity, fMRI, Clinical Classification
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
100
Nanjing
2024-10-20
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
35
Nanjing
2024-10-20
Recruiting
Fudan University
Phase 4
756
Harbin, Changzhou, Nanjing, Yangzhou, Shanghai, Hangzhou, Ningbo
2024-10-18
Active, closed
The First Affiliated Hospital with Nanjing Medical University
Phase 2
47
Nanjing
2024-10-16
Not yet open
Peking University Third Hospital
Early Phase 1
7
Beijing, Fujian, Nanjing, Chengdu, Hangzhou
2024-10-16
Recruiting
Boehringer Ingelheim
Phase 2
588
Beijing, Changsha, Hangzhou, Hefei, Nanchang, Nanjing, Shanghai, Wuhan
2024-10-11
Recruiting
Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery
NCT06778811Sleep Wake Disorders, Esketamine and the Quality of Recovery, Dexmedetomidine
Nanjing First Hospital, Nanjing Medical University
Phase 4
180
Nanjing
2024-10-11
Active, closed
The First Affiliated Hospital with Nanjing Medical University
Phase 2
35
Nanjing
2024-10-09
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
200
Nanjing
2024-10-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-10
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
40
Nanjing
2024-09-30
By invitation
Clinical Trial of Anovulatory Infertility
NCT06601452Polycystic Ovary Syndrome, Diminished Ovarian Reserve, Ovulation Disorder
Affiliated Hospital of Nanjing University of Chinese Medicine
Early Phase 1
650
Nanjing
2024-09-30
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Xi'an, Shanghai
2024-09-26
Recruiting
Sun Yat-sen University
Phase 3
422
Guangzhou, Guilin, Changsha, Nanjing
2024-09-20
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing, Xuzhou, Yancheng
2024-09-20
Not yet open
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
60
Hefei, Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Nanjing, Nanchang
2024-09-20
Recruiting
GlaxoSmithKline
Phase 3
440
Beijing, Chengdu, Guangzhou, Hangzhou, Mianyang, Nanjing, Nanning, Shanghai
2024-09-11
Recruiting
Adebrelimab and Chidamide for Pancreatic Cancer
NCT06584227Pancreatic Cancer, Adult
Liu Xiufeng
Phase 2
45
Nanjing
2024-09-10
Active, closed
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xi’an
2024-09-03
Active, closed
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
304
Nanjing
2024-09-03
Not yet open
Nanjing University
Phase 4
300
Nanjing
2024-09-01
Recruiting
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
NCT06676527Neoplasms, Kidney Neoplasms, Urologic Neoplasms, Urogenital Neoplasms
Jinling Hospital, China
Observational
39
Nanjing
2024-09-01
Recruiting
Tang-Du Hospital
Not applicable
96
Wuhan, Nanjing, Shenyang, Xi'an, Chengdu, Ürümqi, Chongqing, Shanghai
2024-09-01
Active, closed
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
48
Nanjing
2024-09-01
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
76
Nanjing
2024-09
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Beijing, Chengdu, Guangzhou, Hangzhou, Nanchang, Nanjing, Wuhan
2024-08-28
Active, closed
MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
NCT06640153Gastric Cancer, Gastroesophageal Junction Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-08-21
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Not applicable
60
Nanjing
2024-08-21
Recruiting
Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes
NCT06891157Chidamide, R-CHOP Chemotherapy, DLBCL - Diffuse Large B Cell Lymphoma, Double-expressor Lymphoma (DEL)
DrugsR-Chop·Chidamide
The First Affiliated Hospital with Nanjing Medical University
Phase 2
148
Nanjing
2024-08-20
Recruiting
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Early Phase 1
12
Nanjing
2024-08-15
Active, closed
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study
NCT06461338Non-small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma
Guangzhou University of Traditional Chinese Medicine
Not applicable
60
Guangzhou, Nanjing
2024-08-15
Recruiting
DK Medical Technology (Suzhou) Co., Ltd.
Not applicable
140
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Shanghai
2024-08-13
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
100
Nanjing
2024-08-12
Active, closed
Posterior Minimally Invasive Surgery for Treating Paralytic Scoliosis With Pelvic Obliquity in Children Following Spinal Cord Injury
NCT07594574Paralytic Scoliosis, Pelvic Obliquity, Spinal Cord Injury, Neuromuscular Scoliosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
39
Nanjing
2024-08-10
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
22
Nanjing
2024-08-08
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-08-06
Active, closed
Amgen
Phase 4
102
Beijing, Chongqing, Guangzhou, Harbin, Huaian, Nanjing, Suzhou, Xuzhou
2024-08-06
Recruiting
Akeso
Phase 3
469
Zhengzhou, Changsha, Nanjing, Hangzhou
2024-08-02
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
144
Nanjing
2024-08-01
By invitation
Ye jinjun
Phase 3
79
Nanjing
2024-08-01
Recruiting
Yang Tao
Not applicable
80
Nanjing
2024-08-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
320
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Dalian, Jinan, Xi’an
2024-07-31
Recruiting
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
NCT07691125Short Bowel Syndrome (SBS) in Adults
DrugRhGH
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 4
100
Xiamen, Nanjing
2024-07-31
Recruiting
Xintian Pharmaceutical
Phase 4
234
Chongqing, Xiamen, Guangzhou, Shenzhen, Shunde, Wuhan, Nanjing, Xuzhou
2024-07-30
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Recruiting
PulseSelect™ PFA Global Registry
NCT06393920Atrial Fibrillation
Medtronic Cardiac Ablation Solutions
Observational
1,950
Beijing, Fuzhou, Harbin, Kunming, Nanjing, Shanghai, Shenzhen, Ürümqi
2024-07-23
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,332
Nanjing
2024-07-17
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
45
Nanjing
2024-07-10
Recruiting
baotai Liang
Phase 2
30
Nanjing
2024-07-05
Not yet open
Beijing Anzhen Hospital
Not applicable
96
Beijing, Changsha, Kunming, Nanjing
2024-07-01
Recruiting
Recurrent Liver Cancer: Reconceptualization and Reevaluation
NCT06430983Recurrent Liver Cancer, Primary Liver Cancer
Nanjing Medical University
Observational
300
Nanjing
2024-07-01
Recruiting
DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis
NCT06527963Arteriovenous Fistula, Angioplasty, Balloon, Hemodialysis Access Failure
RenJi Hospital
Observational
180
Zhengzhou, Nanjing, Shanghai
2024-07-01
Recruiting
Zhongda Hospital
Observational
180
Nanjing
2024-07-01
Not yet open
The First Affiliated Hospital with Nanjing Medical University
Not applicable
66
Hefei, Zhengzhou, Nanjing, Beijing
2024-07-01
Recruiting
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
NCT07777744Ventricular Tachycardia (VT), Premature Ventricular Complexes
University Hospital, Basel, Switzerland
Observational
15,000
Nanjing
2024-07-01
Recruiting
Peking University People's Hospital
Observational
30
Beijing, Chengdu, Guangdong, Kunming, Nanjing, Nanning, Nanyang, Ningbo
2024-07-01
Recruiting
Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)
NCT06195267Aortic Dissection, Systemic Inflammatory Response Syndrome, Cardiovascular Diseases (CVD)
DrugSivelestat
Nanjing Medical University
Not applicable
500
Beijing, Nanjing
2024-07-01
Active, closed
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
93
Nanjing, Hangzhou
2024-07-01
By invitation
Nanjing Medical University
Not applicable
60
Nanjing
2024-06-30
Recruiting
Nanjing First Hospital, Nanjing Medical University
Not applicable
15
Nanjing
2024-06-30
Recruiting
Boehringer Ingelheim
Phase 1/2
910
Changchun, Hangzhou, Harbin, Nanjing, Shanghai, Tianjin, Zhengzhou
2024-06-28
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
316
Beijing, Fuzhou, Guangzhou, Nanning, Zhengzhou, Changsha, Nanjing, Shanghai
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Beijing, Chongqing, Dongguan, Guangzhou, Hangzhou, Hengyang, Jining, Nanjing
2024-06-20
Recruiting
the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children
NCT05911893Malnutrition, Child, Malnourishment, Nutritional Deficiency, Undernutrition
Children's Hospital of Chongqing Medical University
Not applicable
200
Hefei, Beijing, Jilin City, Chongqing, Guangzhou, Guiyang, Changsha, Nanjing
2024-06-17
Recruiting
RemeGen Co., Ltd.
Phase 1/2
24
Guangzhou, Wuhan, Changsha, Nanjing, Chengdu, Tianjin
2024-06-14
Recruiting
Zekuan Xu
Phase 2
30
Nanjing
2024-06-14
Recruiting
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
NCT06461377Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)
DrugSemaglutide
The First Affiliated Hospital with Nanjing Medical University
Phase 4
50
Nanjing
2024-06-13
Active, closed
GlaxoSmithKline
Phase 3
88
Chengdu, Hangzhou, Hefei, Nanjing, Shanghai
2024-06-10
Recruiting
Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability
NCT06430554Respiratory Distress Syndrome, Positive-Pressure Respiration, Mechanical Ventilation
Zhongda Hospital
Observational
40
Nanjing
2024-06-08
Recruiting
AstraZeneca
Observational
850
Beijing, Changsha, Chengdu, Guangzhou, Hefei, Nanjing, Nanning, Shanghai
2024-06-05
Recruiting
A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
NCT06539689Peripheral Arterial Disease, Stenosis, Dissection
FrontAce Scientific Co., Ltd
Not applicable
240
Beijing, Chongqing, Shijiazhuang, Zhengzhou, Wuhan, Nanjing, Nantong, Shanghai
2024-06-04
Recruiting
RenJi Hospital
Observational
180
Zhengzhou, Nanjing, Shanghai
2024-06-01
Not yet open
The Second Hospital of Nanjing Medical University
Not applicable
32
Nanjing
2024-06-01
Active, closed
Hong Kong Metropolitan University
Not applicable
32
Changzhou, Nanjing, Hong Kong
2024-06-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
40
Nanjing
2024-06-01
Active, closed
Prediction of Detoxification Effect of Fat Emulsion Based on Drug Diffusion Law
NCT06926439Poisoning, Toxicokinetics, Lipid Emulsion
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
85
Nanjing
2024-06-01
Not yet open
Faming Zhang
Not applicable
96
Nanjing
2024-06
Not yet open
Faming Zhang
Not applicable
96
Nanjing
2024-06
Active, closed
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2024-05-31
Not yet open
Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
NCT06426758Graves Disease, Graves' Disease in Remission, Epstein-Barr Virus
Xiao-Ming Mao
Observational
300
Nanjing
2024-05-30
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Beijing, Changsha, Chengdu, Fuzhou, Hanzhou, Kunming, Nanjing, Shanghai
2024-05-30
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Beijing, Fuzhou, Guangzhou, Zhengzhou, Nanjing, Tianjin, Hanzhou
2024-05-24
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Guangzhou, Shantou, Nanjing, Suzhou, Nanchang, Pingxiang, Changchun, Linyi
2024-05-21
Recruiting
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NCT06118840Intracranial Aneurysm, CT Angiography, Deep Learning, Double Bind Interaction
Jinling Hospital, China
Not applicable
6,450
Hefei, Wuhu, Guiyang, Zhengzhou, Shiyan, Nanjing, Xuzhou, Changchun
2024-05-20
Active, closed
AbbVie
Phase 3
421
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Suzhou, Nanchang
2024-05-19
Recruiting
Screening of Biomarkers and Related Mechanisms for RIX
NCT07170358Xerostomia Due to Radiotherapy (Disorder)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
50
Nanjing, Hangzhou
2024-05-17
Recruiting
The Second Hospital of Nanjing Medical University
Phase 2
40
Nanjing
2024-05-16
Not yet open
Guangdong Ruishun Biotech Co., Ltd
Phase 1
24
Beijing, Nanjing, Shanghai
2024-05-15
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
68
Nanjing
2024-05-10
Not yet open
Multiple Study of Electroaccpuncture in ARDS
NCT06278675Acute Respiratory Distress Syndrome, Sepsis
Nanjing University of Traditional Chinese Medicine
Not applicable
264
Nanjing
2024-05-10
Recruiting
Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）
NCT06912321Type 2 Diabetes, Insulin Resistance, Cognitive Impairment
Nanjing First Hospital, Nanjing Medical University
Observational
400
Nanjing
2024-05-01
Not yet open
The Second Hospital of Nanjing Medical University
Not applicable
40
Nanjing
2024-05-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
112
Changzhou, Nanjing, Nantong, Taizhou, Yancheng
2024-05-01
Not yet open
Concomitant Tricuspid Repair in Patients With Left Heart Surgery
NCT05595187Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
400
Nanjing
2024-05-01
Recruiting
The Second Hospital of Nanjing Medical University
Phase 2
144
Nanjing
2024-05
Recruiting
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
NCT06539182Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
DrugBirelentinib
Dizal Pharmaceuticals
Phase 2
155
Hefei, Beijing, Guangzhou, Zhengzhou, Wuhan, Nanjing, Changchun, Dalian
2024-04-29
Recruiting
The Second Hospital of Nanjing Medical University
Observational
50
Nanjing
2024-04-28
Not yet open
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
NCT06340828Diabetic Gastroparesis, Diabetic Gastropathy, Diabetic Gastroenteropathy, Diabetic Gastroparesis Associated With Type 2 Diabetes Mellitus
The Second Hospital of Nanjing Medical University
Not applicable
40
Nanjing
2024-04-20
Recruiting
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NCT06405217DTC - Differentiated Thyroid Cancer, Thyroid Stimulating; Hormone, C, Radiotherapy; Complications
DrugRecombinant Human Thyroid Stimulating Hormone
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2024-04-20
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanjing, Shanghai
2024-04-18
Recruiting
The Second Hospital of Nanjing Medical University
Phase 1
30
Nanjing
2024-04-17
Recruiting
Shandong University
Phase 2
83
Changsha, Nanjing, Jinan, Qingdao, Taiyuan, Hangzhou
2024-04-15
Recruiting
Kuirong Jiang
Not applicable
53
Nanjing
2024-04-08
By invitation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
300
Nanjing
2024-04-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Suzhou
2024-04-03
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2024-04-02
Recruiting
The Second Hospital of Nanjing Medical University
Not applicable
46
Nanjing
2024-04-01
Recruiting
Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
NCT06341595Gastric Cancer, Gastric Cancer Metastatic to Regional Lymph Nodes
DrugsTeysuno·Sintilimab·Oxaliplatin
The First Affiliated Hospital with Nanjing Medical University
Phase 2
40
Nanjing
2024-04-01
Recruiting
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response
NCT06467864Pneumonia, Ventilator-Associated, Respiratory Tract Infections, Prognosis
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2024-04-01
Recruiting
Nanjing Medical University
Observational
60
Nanjing
2024-04-01
Recruiting
Du Juan
Not applicable
40
Nanjing
2024-04-01
Not yet open
Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive Impairment
NCT06234150Breast Neoplasms, Exercise Therapy, Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction
The First Affiliated Hospital with Nanjing Medical University
Not applicable
90
Nanjing
2024-04-01
Recruiting
Jinling Hospital, China
Early Phase 1
12
Nanjing
2024-04
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
95
Nanjing
2024-03-31
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
400
Beijing, Chongqing, Fuzhou, Anyang, Zhengzhou, Huai'an, Nanjing, Jinan
2024-03-30
Active, closed
Study of JK07 in Patients With Chronic Heart Failure
NCT06369298Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
Salubris Biotherapeutics Inc
Phase 2
282
Changsha, Nanjing, Jining, Chengdu, Beijing, Chongqing
2024-03-28
Active, closed
A Study of Efficacy and Safety of TLL-018 in CSU Participants
NCT06396026Chronic Spontaneous Urticaria
DrugTLL-018
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 3
440
Nanjing
2024-03-27
Recruiting
Medtecx Co Ltd.
Not applicable
126
Hefei, Beijing, Wuhan, Nanjing, Nanchang, Xi'an, Shanghai, Tianjin
2024-03-26
Recruiting
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
180
Beijing, Chongqing, Zhengzhou, Nanjing, Shenzhen
2024-03-22
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
80
Zhengzhou, Nanjing, Suzhou, Shanghai, Wenzhou
2024-03-19
Recruiting
Nanjing First Hospital, Nanjing Medical University
Phase 4
40
Nanjing
2024-03-15
Recruiting
AstraZeneca
Phase 3
100
Beijing, Changchun, Changsha, Dongguan, Nanjing, Shanghai, Suzhou, Wenzhou
2024-03-14
Active, closed
Nanjing First Hospital, Nanjing Medical University
Observational
500
Nanjing
2024-03-12
Recruiting
Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCL
NCT07884708Double Expressor DLBCL, ELDERLY PEOPLE, Unfit, New-diagnosis DLBCL
DrugChidamide
The First Affiliated Hospital with Nanjing Medical University
Phase 2
38
Nanjing
2024-03-11
Recruiting
Suzhou Genhouse Bio Co., Ltd.
Phase 1/2
94
Hefei, Zhengzhou, Changsha, Nanjing, Shanghai, Linhai
2024-03-05
Recruiting
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
NCT06285279Lupus Nephritis, ANCA-associated Vasculitis, Membranous Nephropathy - PLA2R Induced, IgG4-Related Diseases
DrugFKC289
Nanjing University School of Medicine
Phase 1
24
Nanjing
2024-03-04
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
209
Nanjing
2024-03-01
Recruiting
The Second Hospital of Nanjing Medical University
Observational
50
Nanjing
2024-03-01
Recruiting
Cheng Lei
Not applicable
60
Nanjing
2024-03-01
By invitation
The First Affiliated Hospital with Nanjing Medical University
Observational
300
Nanjing
2024-03-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
56
Nanjing
2024-03-01
Recruiting
Suzhou Municipal Hospital
Not applicable
30
Nanjing, Nantong, Suzhou
2024-03-01
Recruiting
Immunotherapy for Hepatocellular Carcinoma
NCT06241326Hepatocellular Carcinoma, Immunotherapy
The First Affiliated Hospital with Nanjing Medical University
Observational
11,000
Nanjing
2024-03-01
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Beijing, Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Changchun, Jinan
2024-02-28
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Nanjing, Beijing, Shanghai
2024-02-28
Recruiting
Efficacy of Bioceramic Materials for Bone Defects Repair
NCT06249906Bone Lesion, Cartilage Degeneration, Osteo Arthritis Knee, Bone Fracture
Nanjing First Hospital, Nanjing Medical University
Not applicable
10
Nanjing
2024-02-20
Active, closed
AbbVie
Observational
1,200
Beijing, Chongqing, Guangzhou, Nanjing, Shanghai, Chengdu, Jinhua
2024-02-19
Active, closed
Janssen Research & Development, LLC
Phase 2
305
Changzhou, Chengdoucun, Chengdu, Guangzhou, Hangzhou, Harbin, Huizhou, Nanjing
2024-02-16
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2024-02-10
Recruiting
Study SC-101 in Subjects With Advanced Malignancies
NCT06220838Advanced Solid Tumor
Tianjin ConjuStar Biologics Co., Ltd.
Phase 1
100
Beijing, Changsha, Nanjing, Shanghai, Tianjin
2024-02-02
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 3
40
Nanjing
2024-02-02
Recruiting
Nanjing University
Not applicable
590
Nanjing
2024-02-01
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
150
Chongqing, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing, Dalian, Shenyang
2024-02-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
60
Nanjing
2024-02-01
Recruiting
Jiangsu Cancer Institute & Hospital
Observational
60
Nanjing
2024-02-01
Recruiting
Zhongda Hospital
Not applicable
5
Nanjing
2024-02-01
Recruiting
Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple Myeloma
NCT07907211Multiple Myeloma, Venous Thromboembolism (VTE)
DrugsRivaroxaban·Aspirin
Chen Lijuan
Phase 4
200
Nanjing
2024-02-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
768
Nanjing
2024-01-28
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2024-01-26
Recruiting
Tongji Hospital
Observational
250
Wuhan, Beijing, Changchun, Chongqing, Nanjing
2024-01-20
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
33
Nanjing, Chengdu, Ningbo
2024-01-19
Recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
NCT06220617Colorectal Cancer, Adenomatous Polyps, Adenoma, Advanced Adenoma
Zhejiang University
Observational
3,600
Hangzhou, Guangzhou, Kunming, Nanjing, Xi'an, Zhengzhou
2024-01-11
Recruiting
Jin Lu, MD
Not applicable
41
Beijing, Nanjing, Qingdao, Xi’an
2024-01-05
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
54
Nanjing
2024-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
37
Nanjing
2024-01-01
Recruiting
Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models
NCT06848959Cerebral Palsy, Mental Retardation, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder
Yun Liu,PhD
Observational
2,000
Nanjing
2024-01-01
Not yet open
Randomized Controlled Study of Optical 3D Navigated Repetitive Transcranial Magnetic Stimulation for Achalasia.
NCT06027190Esophageal Achalasia, Transcranial Magnetic Stimulation, Repetitive, Vagus Nerve Motor Disorder, Functional Magnetic Resonance Imaging
Zhang Nina
Not applicable
112
Nanjing
2024-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
102
Nanjing
2024-01-01
Recruiting
Nanjing Medical University
Observational
150
Nanjing
2024-01-01
Recruiting
CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy
NCT06241651Conduction System Pacing, Biventricular Pacing, Cardiac Resynchronization Therapy, Right Ventricular Pacing
The First Affiliated Hospital with Nanjing Medical University
Not applicable
66
Nanjing
2024-01-01
Recruiting
Central South University
Observational
2,000
Hefei, Zhengzhou, Changsha, Nanjing
2024-01-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
74
Nanjing
2024-01-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing
2023-12-31
Active, closed
Xiamen University
Observational
392
Nanjing
2023-12-30
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Suzhou, Tianjin, Zhengzhou
2023-12-29
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Nanjing
2023-12-27
Recruiting
Teligene US
Phase 2
66
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanjing, Nanchang, Jinan
2023-12-27
Recruiting
RenJi Hospital
Not applicable
1,200
Nanjing, Nanchang, Jinan, Shanghai, Xi’an, Tianjin, Hangzhou
2023-12-27
Recruiting
Zhongda Hospital
Not applicable
188
Beijing, Nanjing
2023-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Wuhan, Changsha, Nanjing
2023-12-18
Recruiting
The Second Hospital of Nanjing Medical University
Observational
100
Nanjing
2023-12-17
Recruiting
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
NCT06255223Renal Cell Carcinoma, Radiotherapy, Immune Checkpoint Inhibitor
Jinling Hospital, China
Phase 2
35
Nanjing
2023-12-15
Recruiting
Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
NCT06177015Metastatic Prostate Cancer, Intermitent Anti-androgen Therapy
DrugDarolutamide
The First Affiliated Hospital with Nanjing Medical University
Phase 3
200
Nanjing
2023-12-11
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicable
290
Beijing, Chongqing, Changsha, Nanjing, Suzhou, Shanghai, Xi’an, Chengdu
2023-12-01
Not yet open
Wen-hong Zhang
Observational
5,000
Hefei, Fuzhou, Wuhan, Nanjing, Xuzhou, Jinan, Taiyuan, Xi’an
2023-12-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
50
Nanjing
2023-12-01
Recruiting
Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis
NCT06162767Esophagogastric Junction Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
240
Nanjing
2023-12-01
Recruiting
Southeast University, China
Not applicable
404
Hefei, Jinjiang, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Taizhou
2023-11-27
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
1,163
Nanjing
2023-11-17
Recruiting
RenJi Hospital
Phase 2
22
Nanjing, Xi'an, Shanghai, Chengdu, Tianjin
2023-11-16
Active, closed
AbbVie
Phase 3
289
Chongqing, Xiamen, Guangzhou, Wuhan, Changsha, Changzhou, Nanjing, Wuxi
2023-11-15
Recruiting
Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
NCT06125925Atrial Fibrillation, HFpEF - Heart Failure With Preserved Ejection Fraction
The First Affiliated Hospital with Nanjing Medical University
Not applicable
436
Nanjing
2023-11-06
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
70
Nanjing
2023-11-01
Recruiting
Yun Chen
Observational
178
Nanjing
2023-11-01
Recruiting
Mao Jianhua
Phase 3
140
Wuhan, Nanjing, Kunming, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2023-11-01
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
868
Nanjing
2023-11-01
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Hefei, Chongqing, Guangzhou, Shenzhen, Wuhan, Baotou, Nanjing, Nanchang
2023-10-27
Recruiting
OriCell Therapeutics Co., Ltd.
Phase 1/2
83
Hangzhou, Beijing, Nanjing, Shanghai, Wuhan
2023-10-26
Not yet open
Hangzhou Dinova EP Technology Co., Ltd
Not applicable
242
Nanjing
2023-10-20
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
180
Beijing, Fuzhou, Zhengzhou, Changsha, Nanjing, Nanchang, Changchun, Jinan
2023-10-19
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
200
Nanjing
2023-10-17
By invitation
Biogen
Phase 3
306
Beijing, Shenzhen, Dongguan, Guangzhou, Changsha, Nanjing, Shanghai, Kunming
2023-10-03
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
2,800
Nanjing
2023-10-01
Recruiting
Jiangsu Renocell Biotech Company
Phase 1/2
81
Nanjing
2023-09-22
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
86
Nanjing
2023-09-21
Recruiting
The Second Hospital of Nanjing Medical University
Observational
80
Nanjing
2023-09-20
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
258
Nanjing
2023-09-17
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Beijing, Changchun, Chengdu, Luzhou, Mianyang, Nanjing, Nanning, Shanghai
2023-09-13
By invitation
argenx
Phase 3
240
Guangzhou, Nanjing, Beijing, Chengdu, Shanghai, Shenyang, Zhengzhou
2023-09-12
Recruiting
Omission of ALND in Breast Cancer Patients With Axillary pCR
NCT05939830Axillary Lymph Node Dissection, Pathological Complete Response, Neoadjuvant Systemic Therapy, Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
92
Nanjing
2023-09-11
Active, closed
Effect of Low-dose Esketamine on Maternal Depression at 3 Years After Childbirth
NCT05698394Prenatal Depression, Ketamine, Postpartum Depression
DrugEsketamine
Peking University First Hospital
Phase 4
364
Changsha, Nanjing, Hangzhou, Beijing
2023-09-09
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2/3
254
Guangzhou, Liuzhou, Anyang, Luoyang, Shijiazhuang, Harbin, Wuhan, Nanjing
2023-09-08
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
102
Nanjing
2023-09-07
Not yet open
Qilu Pharmaceutical Co., Ltd.
Phase 2/3
668
Nanjing, Shanghai
2023-09-01
Recruiting
Nanjing Medical University
Observational
400
Nanjing
2023-09-01
Not yet open
Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
NCT05730595Colorectal Neoplasms, Fluorescence, Lymph Node Excision
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
550
Hefei, Beijing, Chengdu, Fuzhou, Guangzhou, Shijiazhuang, Haerbin, Nanjing
2023-09-01
Active, closed
Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
NCT05784519Mesenchymal Stem Cell, Dry Eye Syndromes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Early Phase 1
10
Nanjing
2023-09-01
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
500
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Nanchang, Shanghai
2023-08-28
Recruiting
AstraZeneca
Phase 3
231
Beijing, Changchun, Hohhot, Lanzhou, Nanjing, Shanghai, Shenyang, Shenzhen
2023-08-24
Active, closed
Han Ying
Phase 2/3
184
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Yan’an, Kunming, Beijing
2023-08-21
Recruiting
DualityBio Inc.
Phase 1/2
1,000
Zhengzhou, Changsha, Nanjing, Wuxi, Changchun, Shenyang, Shanghai, Chengdu
2023-08-17
Recruiting
Jiangsu Renocell Biotech Company
Phase 2
60
Nanjing
2023-08-17
Active, closed
Sun Yat-sen University
Not applicable
620
Beijing, Fuzhou, Lanzhou, Dongguan, Foshan, Guangzhou, Wuhan, Nanjing
2023-08-16
Active, closed
Zhongda Hospital
Phase 1/2
10
Nanjing
2023-08-07
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
200
Nanjing
2023-08-06
Recruiting
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
NCT05983783Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemotherapy Effect
DrugsRezvilutamide·Docetaxel
The First Affiliated Hospital with Nanjing Medical University
Phase 3
200
Nanjing
2023-08-01
Recruiting
The Second Hospital of Nanjing Medical University
Phase 1/2
18
Nanjing
2023-07-24
Recruiting
Jinling Hospital, China
Not applicable
386
Nanjing
2023-07-22
Recruiting
Washed Microbiota Transplantation for Clostridioides Difficile Infection
NCT06106698Clostridioides Difficile Infection
The Second Hospital of Nanjing Medical University
Observational
100
Nanjing
2023-07-22
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Nanchang
2023-07-11
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
NCT05727176Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2
120
Guangzhou, Harbin, Nanjing, Changchun, Jinan, Shanghai, Chengdu, Hangzhou
2023-07-05
Recruiting
Base Therapeutics (Shanghai) Co., Ltd.
Early Phase 1
12
Nanjing
2023-07-01
By invitation
Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography
NCT06025305Coronary Artery Disease, Plaque, Atherosclerotic
Jinling Hospital, China
Observational
2,000
Nanjing
2023-07-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
428
Nanjing
2023-07-01
Recruiting
Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population
NCT05725096Statin, Cardiovascular Risk Factors, Primary Prevention, Adherence, Medication
Zhang longjiang,MD
Not applicable
3,400
Nanjing
2023-06-28
Active, closed
Fu Wai Hospital, Beijing, China
Not applicable
36
Beijing, Nanjing
2023-06-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Zhengzhou, Changsha, Nanjing
2023-06-22
Recruiting
Omission of SLNB in CN0 Early Breast Cancer
NCT05935150Breast Cancer, Clinically Assessed Negative Axillary Lymph Nodes, Sentinel Lymph Node
The First Affiliated Hospital with Nanjing Medical University
Not applicable
311
Nanjing
2023-06-21
Recruiting
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
NCT05956639Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
DrugRezvilutamide
The First Affiliated Hospital with Nanjing Medical University
Phase 3
100
Nanjing
2023-06-20
Recruiting
Hansoh BioMedical R&D Company
Phase 2
170
Beijing, Changsha, Guangzhou, Hangzhou, Nanjing, Shanghai, Tianjin, Zhengzhou
2023-06-08
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 3
104
Nanjing
2023-06-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
24
Nanjing
2023-06-01
Recruiting
Istituto Giannina Gaslini
Observational
2,000
Nanjing
2023-05-30
Recruiting
Dongzong Cardiovascular Bio-imaging Registry Study
NCT06894095Cardiovascular Diseases, Multi-omics, Living Environments, Pulmonary-cardiovascular Imaging
Jinling Hospital, China
Observational
50,000
Nanjing, Suqian, Zhenjiang
2023-05-24
Recruiting
Pfizer
Phase 3
318
Hefei, Beijing, Dongguan, Guangzhou, Cangzhou, Changsha, Nanjing, Nanchang
2023-05-20
Recruiting
Novlead Inc.
Not applicable
16
Nanjing
2023-05-17
Recruiting
Ton-Bridge Medical Tech. Co., Ltd
Not applicable
200
Luoyang, Wuhan, Nanjing, Nanchang, Changchun, Dalian, Baotou, Kunming
2023-05-11
Active, closed
Novartis Pharmaceuticals
Phase 2
63
Wuhan, Nanjing, Shenyang, Xian, Chengdu, Hangzhou, Beijing, Guangzhou
2023-05-05
Active, closed
CRUSTAL Study in China
NCT05828186Coronary Artery Disease, Calcification
First Affiliated Hospital of Guangxi Medical University
Observational
200
Liuzhou, Yulin, Nanjing, Guilin, Guiping
2023-05-04
Recruiting
Jiangsu Province Nanjing Brain Hospital
Not applicable
150
Nanjing
2023-04-19
Recruiting
Immunotherapy with Autologous Tregs in T1DM
NCT06708780Type 1 Diabetes Mellitus
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1
20
Nanjing
2023-04-12
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
100
Nanjing
2023-04-12
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 4
2,260
Nanjing, Changzhou, Chongqing, Dalian, Daqing, Dongguan, Fengcheng, Guangzhou
2023-04-08
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 2
188
Nanjing
2023-04-08
Recruiting
IVUS-guided DES Implantation in Coronary Calcification
NCT05800002Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University
Not applicable
864
Nanjing
2023-04-07
Active, closed
Bayer
Phase 3
985
Beijing, Wuhan, Changsha, Nanjing, Shanghai, Chengdu, Tianjin, Hangzhou
2023-04-03
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2023-04-01
Not yet open
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
103
Nanjing, Nantong
2023-04-01
Recruiting
TransThera Sciences (Nanjing), Inc.
Phase 1
37
Nanjing
2023-03-30
Active, closed
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
NCT05457582Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention, Cardiovascular Events
DrugHigh-intensity statin
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,212
Nanjing
2023-03-30
Recruiting
Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations
NCT06041776Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy
Betta Pharmaceuticals Co., Ltd.
Phase 3
570
Beijing, Nanjing, Shanghai
2023-03-28
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
140
Wuhan, Nanjing, Taiyuan
2023-03-15
Active, closed
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
219
Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an
2023-03-09
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Guangzhou, Shantou, Haikou, Zhuzhou, Nanjing, Suzhou, Nanchang, Pingxiang
2023-03-02
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
96
Nanjing
2023-03
Recruiting
Shanghai AbelZeta Ltd.
Phase 1/2
112
Beijing, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai
2023-02-22
Recruiting
Xijing Hospital of Digestive Diseases
Phase 3
150
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Chengdu, Tianjin
2023-02-22
Recruiting
The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer
NCT06702683Gastric Carcinoma, Gastric Neoplasm, Gastric (cardia, Body) Cancer, Gastric Cancer Adenocarcinoma Metastatic
Lin Liu
Observational
112
Nanjing
2023-02-17
Recruiting
Xijing Hospital of Digestive Diseases
Phase 2/3
104
Beijing, Guangzhou, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an, Yan’an
2023-02-17
Recruiting
Juventas Cell Therapy Ltd.
Phase 1/2
47
Hefei, Chongqing, Guangzhou, Wuhan, Nanjing, Xuzhou, Nanchang, Tianjin
2023-02-07
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
30
Nanjing, Nanning
2023-02-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 3
130
Nanjing
2023-01-31
Active, closed
The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection（BROAD）
NCT05659641Aortic Dissection, Aneurysm, Dissecting, Aneurysm, Vascular Diseases
Permed Biomedical Engineering Co., Ltd
Not applicable
259
Hefei, Chongqing, Fuzhou, Shijiazhuang, Harbin, Wuhan, Nanjing, Nanchang
2023-01-18
Active, closed
Bristol-Myers Squibb
Phase 3
606
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Nantong
2023-01-10
By invitation
The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens
NCT07035535Antimicrobial Drug Resistance, High-Throughput Nucleotide Sequencing
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2023-01-01
Active, closed
Guangming Lu
Observational
2,000
Nanjing
2023-01-01
Active, closed
3D-CT-Based Prediction of Difficult Laryngoscopy in Infants With Pierre Robin Sequence
NCT07257276Pierre Robin Sequence (PRS), Difficult Laryngoscopy, Airway Management
Nanjing Children's Hospital
Observational
294
Nanjing
2023-01-01
Recruiting
Daratumumab for Patients With Light Chain Amyloidosis
NCT06376214Light Chain (AL) Amyloidosis
DrugsDara·Pomalidomide
Nanjing University School of Medicine
Not applicable
100
Nanjing
2023-01-01
Recruiting
Nanjing Children's Hospital
Not applicable
110
Nanjing
2023-01-01
Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
NCT05917106Carcinoma, Renal Cell Carcinoma, RCC, Kidney Neoplasms
Jinling Hospital, China
Observational
450
Nanjing
2022-12-26
Recruiting
Jinling Hospital, China
Not applicable
236
Nanjing
2022-12-08
Recruiting
Fourth Affiliated Hospital of Guangxi Medical University
Not applicable
288
Baise City, Guilin, Liuzhou, Nanjing, Qinzhou, Wuzhou
2022-12-01
Recruiting
Jiangsu Famous Medical Technology Co., Ltd.
Phase 3
730
Nanjing
2022-12-01
Not yet open
Nanjing University of Traditional Chinese Medicine
Not applicable
90
Nanjing
2022-12-01
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
4,500
Changzhou, Huai'an, Nanjing, Suqian, Suzhou
2022-12
Rows per page Showing 501–1000 of 1211
Previous 1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/nanjing?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,211 of those studies with a site in Nanjing.

How many clinical trials are recruiting in Nanjing?

725 of the 1,211 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 237 have not yet opened recruitment, 216 are active but closed to new participants, and 33 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.